2Candianerythropoietinstudygroup.Associationbetweenrecombinanthumanerythropoietinandqualityoflifeandexecisecapacityofpatientsreceivinghaemodialysis[].British Medical Journal.1990
4Clinical practice guidelines and Clinical practice recommendations for animia in chronic kidney disease in adults[J].American Journal of Kidney Diseases,2006,47(Suppl 3):S16-S85.
5Clinical practice recommendations for animia in chronic kidney disease in transplant recipients[J],American Journal of Kidney Diseases,2006,47(Suppl 3):S109-Sl16.
6Panletti E,Cannella G.Update on erythropoietin treatment:should hemoglobin be normalized in patients with chronic kidney disease[J].J Am Soc Nephrol,2006,17(Suppl 2):S74-S77.
7Chatterjee PK.Pleiotropic renal actions of erythropoietin[J].Lancet,2005,365(9474):1890-1892.
8Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure[J].Nephrol Dial Transplant,2004,19(Suppl 2):ii1-ii47.
9Collins AJ.Anaemia management prior to dialysis:cardiovascular and cost-benefit observations[J].Nephrol Dial Transplant,2003,18 (Suppl 2)::2-6.
10de Francisco AL,Fernandez Fresnedo G,et al.Past,present and future of erythropoietin use in the elderly[J].Int Urol Nephrol,2002,33(1):187-193.
